ArticleAntimicrobial agents and chemotherapy2019
Antimicrobial Treatment Provides a Competitive Advantage to Mycobacterium abscessus in a Dual-Species Biofilm with Pseudomonas aeruginosa.
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Article
- Co-infection withFrontiers in medicine · 2026Review
- Pathogenicity and virulence ofVirulence · 2025Review
- Interplay ofVirulence · 2025Article
- Insights on the Pathogenesis ofJournal of clinical medicine · 2025Review
- Article
- Article
- Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery.npj antimicrobials and resistance · 2024Review
- Cystic fibrosis sputum media induces an overall loss of antibiotic susceptibility in Mycobacterium abscessus.npj antimicrobials and resistance · 2024Article
- Polymicrobial interactions influenceFrontiers in microbiology · 2024Article
- A laboratory perspective onFrontiers in microbiology · 2024Review
- Article
- Characterization ofAntimicrobial agents and chemotherapy · 2023Article
- Updated Review on the Mechanisms of Pathogenicity inMicroorganisms · 2022Review
- Infectious Diseases Impact on Biomedical Devices and Materials.Biomedical materials & devices (New York, N.Y.) · 2022Review
- Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research.Pathogens (Basel, Switzerland) · 2020Review
- Modulated Response ofFrontiers in cellular and infection microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The physiological factors that contribute to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.